Why Am I Not Losing Weight on Weekly Weight Loss Injections?
Weekly weight loss injections like semaglutide and tirzepatide have changed medicine — but they do not work for everyone in the same way. If you have been on a GLP-1 injection for several weeks or months and are not seeing the results you expected, you are not alone, and you are not imagining it. Here are six of the most common reasons weight loss stalls on weekly injections — and what can be done about each.
1. Hormone Imbalance
GLP-1 medications address one piece of the weight puzzle — appetite regulation. They do nothing to correct hormonal imbalances that are independently driving weight gain or preventing weight loss. Estrogen dominance in women, low testosterone in men, suboptimal thyroid function, and elevated insulin can all overpower even a strong GLP-1 response. If your hormones are working against your metabolism, a weekly injection alone is unlikely to produce full results.
Estrogen dominance — where estrogen is high relative to progesterone — promotes fluid retention, fat storage, and inflammation. In perimenopausal women, this pattern is particularly common. Low testosterone in men (increasingly prevalent from the mid-30s onward) reduces muscle mass, impairs fat burning, and promotes insulin resistance. Both are treatable with BHRT, and correcting them can dramatically improve GLP-1 response.
2. Thyroid Dysfunction
The thyroid gland sets the metabolic thermostat for your entire body. Even mild, subclinical hypothyroidism — where TSH is slightly elevated or free T3 is low-normal — can be enough to slow metabolism by 15 to 20 percent. This metabolic drag can easily cancel out the caloric deficit created by semaglutide. Many patients with thyroid dysfunction have been told their labs are "normal" using outdated reference ranges. Comprehensive thyroid testing including free T3, reverse T3, and thyroid antibodies is essential for anyone who is not responding adequately to weekly injections.
3. Muscle Loss
Rapid weight loss — especially without adequate protein intake and resistance exercise — leads to muscle catabolism. As muscle mass declines, so does resting metabolic rate. This creates a vicious cycle: less muscle means fewer calories burned, which means the caloric deficit narrows, which means weight loss slows or stops. Patients who are very sedentary or who have been on very low-protein diets during their injection therapy are most vulnerable to this problem.
The solution involves two-pronged action: increase daily protein to at least 1.2 to 1.6 grams per kilogram of body weight, and begin or increase resistance training. Even two sessions of strength training per week can meaningfully preserve and build muscle during GLP-1 treatment.
4. Sleep Deprivation
Poor sleep is a profoundly underappreciated driver of weight loss resistance. Sleep deprivation elevates ghrelin (the hunger hormone) and suppresses leptin (the satiety hormone), counteracting the very appetite regulation that GLP-1 medications are designed to support. Even with semaglutide on board, inadequate sleep can re-amplify hunger signals enough to undermine caloric restriction.
Sleep deprivation also raises cortisol, reduces insulin sensitivity, and suppresses growth hormone release — all of which promote fat storage. Adults typically need seven to nine hours of quality sleep per night. Sleep apnea — which is common in overweight individuals — prevents restorative sleep and should be screened for and treated if present.
5. Chronic Stress
Cortisol, the primary stress hormone, directly promotes fat storage — particularly visceral abdominal fat. It also increases appetite for calorie-dense foods, drives insulin resistance, breaks down muscle, and suppresses thyroid function. If you are living under chronic high stress — work, relationships, financial pressure, unresolved trauma — the cortisol load may be enough to block meaningful weight loss even on a GLP-1 medication.
Stress management is not optional in a comprehensive weight loss program. Mindfulness practice, consistent sleep, adequate leisure time, and sometimes targeted adrenal support through BHRT (including DHEA supplementation to balance cortisol) can address the stress component effectively.
6. Dose Issues
Not every patient responds adequately at the same dose of semaglutide or tirzepatide. Some individuals are rapid metabolizers of the medication, or have GLP-1 receptor variants that reduce drug sensitivity. If you are on a submaximal dose and have tolerated increases well, working toward the maximum therapeutic dose is worth discussing with your physician. Conversely, if you have been on the maximum dose for several months and weight has been stable for eight weeks or more, it may be time to explore combination strategies rather than expecting more from the same approach.
The BHRT Combination Advantage
Many patients who are not fully responding to weekly injections find that adding BHRT unlocks their weight loss potential. Optimizing thyroid hormones, testosterone, estrogen, and cortisol-DHEA balance alongside GLP-1 therapy addresses the full spectrum of metabolic drivers — not just appetite. The combination consistently produces better body composition outcomes than either approach alone.
Get Answers from Dr. Bruice
Kenton Bruice, M.D. specializes in combining GLP-1 therapy with BHRT and comprehensive metabolic care at his practices in Denver, Aspen, and St. Louis. If your weekly injections are not delivering the results you expected, schedule a consultation with Dr. Bruice to get a thorough evaluation and a plan that actually works.